Abstract
Polyalkyl furans are widespread in Nature, often performing important biological roles. Despite a plethora of methods for the synthesis of tetrasubstituted furans, the construction of tetraalkyl furans remains non-trivial. The prevalence of alkyl groups in bioactive furan natural products, combined with the desirable bioactivities of tetraalkyl furans, calls for a general synthetic protocol for polyalkyl furans. This paper describes a Michael–Heck approach, using sequential phosphine–palladium catalysis, for the preparation of various polyalkyl furans from readily available precursors. The versatility of this method is illustrated by the total syntheses of nine distinct polyalkylated furan natural products belonging to different classes, namely the furanoterpenes rosefuran, sesquirosefuran, and mikanifuran; the marine natural products plakorsins A, B, and D and plakorsin D methyl ester; and the furan fatty acids 3D5 and hydromumiamicin.
Keywords: furan synthesis, furan natural products, Michael addition, Heck reaction, phosphine–palladium catalysis
Graphical Abstract

One method to make them all: Highly substituted polyalkyl furans can be synthesized using sequential Michael–Heck reactions between functionalized (Z)-β-halo allylic alcohols and activated alkynes. This method provides facile access to tetraalkyl furans containing a C2-carboxyalkyl chain, which is readily functionalized to enable the total syntheses of several classes of bioactive furans, including furanoterpenes, polyketides, and furan fatty acids.
Furan is a structural motif in a wide variety of bioactive natural products,[1] pharmaceuticals,[2] and useful intermediates in organic synthesis.[3] Polyalkyl furans, in particular, feature prominently in bioactive natural products (Scheme 1A), including the galerucella pheromone;[4] calicogorgins A–C;[1d] furan fatty acids (F-acids),[5] potent antioxidants and radical scavengers that protect polyunsaturated fatty acids from lipid peroxidation; rosefuran,[6] the fragrant component of highly prized rose oil; and plakorsins D[7] and B,[8] cytotoxic F-acid derivatives isolated from the marine sponge P. simplex.
Scheme 1.

Examples of polyalkyl furan natural products and reaction design
Although C2/C5-functionalization of furans can be achieved quite readily through metalation or electrophilic aromatic substitution,[9] the regioselective construction of highly functionalized furans poses a challenge. Among myriad methods available for the syntheses of tetrasubstituted furans, the overwhelming majority provide carbonyl-,[10] thioalkyl-,[11] halo-,[12] amino- and aryl-substituted[13] furans, but very few enable direct access to the tetraalkyl furans[14] that feature prominently in biologically important compounds (e.g., the F-acids). Notably, none of the three known syntheses of tetraalkyl furans[14] have, to the best of knowledge, ever provided furans with four non-identical alkyl substituents. Given the prevalence and desirable bioactivities of polyalkyl furans and the relative paucity of aryl substituents in furan-containing natural products,[15] it would be useful to have the ability to prepare polyalkyl furans efficiently.
(Z)-3-Halo-2-propen-1-ols are versatile substrates that can be obtained rapidly and stereoselectively from readily available propargyl alcohols and alkynoates through hydro/carbometalation–iodinolysis and hydroiodination–reduction sequences, respectively.[16] Having both hydroxyl and vinyl halide functionalities, we have found that they can be integrated seamlessly into sequential phosphine–palladium catalysis, wherein initially the OH group undergoes phosphine-catalyzed (E)-selective Michael addition to activated alkynes to give vinyl ether intermediates,[17a–c] which then undergo sequential Heck cyclization and spontaneous aromatization to give highly substituted furans (Scheme 1B). The phosphine organocatalyst for the Michael addition acts as a ligand in the Heck reaction. The resulting (alkoxycarbonyl)alkyl side chain can then be transformed into other functional groups and homologated.[18–20] Using appropriately substituted (Z)-β-halo allylic alcohols, this approach becomes a general method for the synthesis of various bioactive polyalkyl furans from readily accessible precursors.
Our investigation of the Michael–Heck reaction began with optimization of the Michael addition between the β-iodoallylic alcohol 1m and methyl propiolate (Table S1). The more nucleophilic PBu3 was superior to PPh3 at accelerating the Michael reaction, while nonpolar solvents were preferred over polar ones, delivering the Michael adduct in 96% yield. Next, we examined the Heck reaction using the optimized conditions for the Michael addition (Table S2). A screen of various bases revealed that Et3N containing 1% water was optimal (Table S3).[21] Toluene and MeCN were superior to dioxane as solvents, and Pd(II) catalysts outperformed Pd(0) species. The presence of the phase-transfer agent tetrabutylammonium chloride (TBAC) was essential.[22] Thus, the use of non-anhydrous Et3N and catalytic Pd(OAc)2 in MeCN provided the furan 3m in 97% yield (eq. 1).
![]() |
(1) |
With these optimized conditions in hand, we explored the substrate scope of the Michael–Heck reaction (Table 1). Under conditions A, we obtained the 2-substituted furan 3a in 94% yield. These conditions were also compatible with both C3-alkyl and -aryl groups, delivering the 2,3-disubstituted furans 3a–3k in good yields (53–90%). Elevated temperatures were required in the cases of the bulky 3-isopropyl– and 3-tert-butyl–substituted furans 3c and 3d (conditions A1). Notably, potentially reactive allyl and prenyl groups were inert to the Heck conditions, delivering 3e and 3f, respectively, in good yields. While both electron-donating and -withdrawing substituents on the C3-phenyl ring were tolerated, the reaction was sensitive to steric effects, with meta substituents (3j, 3k) giving substantially lower yields than para (3h, 3i) ones. A similar trend occurred among the 2,4-disubstituted furans, where C2-phenyl compounds containing para electron-withdrawing (3o) and -donating (3p) groups outperformed an ortho-substituted one (3n). While both C4-alkyl (3l) and -aryl (3m) groups were compatible, the use of 3-butyn-2-one (3ĺ, 3m´) and ethynyl phenyl ketone (3m´´) in place of methyl propiolate required slow addition of the alkyne (conditions A2) to prevent rapid polymerization of the Michael acceptor under phosphine catalysis. The ease with which the starting (Z)-3-halo-2-propen-1-ol could be functionalized enabled facile access to both 2,3- and 2,4-functionalized furans, which are difficult to obtain regioselectively when using conventional methods.[23] The standard conditions A were also applicable for the synthesis of 2,5-disubstituted furans, where C5-alkyl (3q, 3r), -cycloalkyl (3s, 3t), and -aryl (3v–3x) groups were all incorporated. No opening of the cyclopropyl ring (3s) occurred, and both bulky cyclohexyl (3t) and 1-naphthyl (3x) groups were compatible. Plakorsin A,[8a] an F-acid derivative from the marine sponge P. simplex, was obtained in 86% yield.
Table 1.
|
All reactions were performed under Ar using anhydrous solvents.
Isolated yields after flash-column chromatography. [c] X = Br
We turned our attention to the preparation of tri- and tetrasubstituted furans. While conditions A1 delivered the aryl-containing trisubstituted furans 3y, 3bb, and 3gg in good yields, they failed for di- or trialkyl-substituted substrates. Because conditions A worked well for the preparation of furans containing at least one electron-withdrawing group, we attempted to make the Michael acceptor more electron-deficient (Scheme S5), but detected no product and obtained copious amounts of polymerized Michael acceptor.[17c] Intrigued by Fu’s report on the use of air-stable trialkylphosphonium salts for various cross-couplings of deactivated aryl chlorides and bromides,[24] we adapted those conditions for our Michael–Heck reaction (eq. 2).
![]() |
(2) |
Using P(t-Bu)3HBF4 along with Cy2NMe as the base, we prepared trialkyl furans with fused cycloalkyl (3z) and linear alkyl (3cc, 3dd, 3ee, 3hh) substituents in moderate to good yields. Plakorsin D methyl ester,[7] a polyketide isolated from the marine sponge P. simplex, was obtained in 64% yield. Significantly, the medicinally relevant CF3 group was compatible, furnishing the furan 3aa in good yield.[25,26] While these conditions failed for the synthesis of tetraalkyl furans, a slight increase in the reaction temperature to 110 °C (from 90 °C for conditions B) and the use of Pd2(dba)3 as a catalyst enabled the preparation of tetraalkyl furans in good yields (eq. 3).
![]() |
(3) |
Whereas the presence of a C3-aryl unit led to a slightly diminished yield (3ii), tetraalkyl furans with either fused cycloalkyl (3kk) or linear alkyl (3jj, 3ll) groups were prepared in good yields. In the cases of 3z and 3kk, we used a vinyl bromide substrate, further highlighting the versatility of this method. Finally, furans substituted with four different alkyl groups (3mm, 3nn) could be prepared in good yields. To the best of your knowledge, this methodology is the first ever reported of result in the synthesis of furans bearing four different alkyl substituents. Among the more than 90 reports describing the syntheses of tetrasubstituted furans, only three have been amenable to the preparation of tetraalkyl furans,[14] and none of them to the synthesis of furans presenting four different alkyl groups. The compatibility of silyl ether groups is also significant, suggesting potential application of this method towards total synthesis of complex furan natural products.
Having demonstrated the wide substrate scope of the Michael–Heck reaction, we explored its applications in the total syntheses of bioactive furans (Scheme 2A). Hydrolysis of plakorsin A produced plakorsin B, known to exhibit strong cytotoxicity against colon carcinoma (COLO-250) cells and weak activity against nasopharyngeal carcinoma (KB-16) cells.[8a] Previous approaches to plakorsins A and B have included Lewis acid–mediated 5-endo-dig cyclization of 3-alkyne-1,2-diols,[27] sequential functionalization of furan through lithiation/alkylation,[28] and electrophilic aromatic substitution of methyl 2-furylacetate[29] and 2-cyanomethylfuran,[29b,30] the latter of which suffered from highly variable yields (23–92%). On the other hand, our Michael–Heck approach reliably furnished plakorsin A from methyl propiolate in 62% yield over three steps. Hydrolysis of plakorsin D methyl ester furnished plakorsin D—its first total synthesis.[31a]
Scheme 2.

Applications of products of Michael–Heck reactions to total syntheses of bioactive furan natural products
Reaction conditions: a) LiAlH4, Et2O, 0 °C, 15 min. b) PPh3, I2, imidazole, THF, rt, 15 min. c) KCN, acetone/water, reflux, 16 h. d) PPh3, neat, 1 h, 80–85 °C
Next, we moved on to the synthesis of 2,3-disubstituted furanoterpenes (Scheme 2B). Reduction of the ester group of the furan 3b produced an alcohol intermediate,[32] which we transformed to a halide. Surprisingly, the bromide was unstable,[33] but the iodide proved to be robust and was converted smoothly to the phosphonium iodide 4 when using PPh3 as the reaction solvent.[34] A subsequent Wittig reaction under Boden’s conditions[35] furnished rosefuran in 97% yield. To prevent complications resulting from lithiation of the free C5 position of 4, we chose KOtBu as the base. We used the same approach for the syntheses of sesquirosefuran[36] and mikanifuran.[37] In these cases, excess ketone and high reaction concentrations were necessary to prevent the formation of 3-methyl-2-vinylfuran as a side product (presumably resulting from E2 elimination of 4).[38] Under these conditions, we obtained sesquirosefuran in 96% yield as a mixture of E/Z isomers. Despite efforts to selectively obtain the E-isomer,[39] the inherent Z-selectivity of Wittig reactions with unstabilized ylides resulted in a mixture of isomers.[40] We also used these conditions to prepare mikanifuran in 56% yield as a mixture of E/Z isomers. In addition to being used in fragrances and spices, rosefuran is also a female sex pheromone in the acarid mite, Caloglyphus sp., capable of triggering sexual excitation at less than 100 ng.[6a,b] While mikanifuran has no known biological activity, sesquirosefuran displays significant cytotoxicity against HeLa cells in vivo.[36] The commercial importance and biological activity of rosefuran has inspired several ingenious syntheses of it and related furanoterpenes. These strategies can be classified into alkylation, transition metal–catalyzed methods, functionalization of cyclic precursors, and cyclization of linear precursors.[41]
For the total synthesis of 3D5, a unique F-acid found in the soft corals S. glaucum and S. gemmatun (Scheme 2C), we employed a sequence of reduction, Appel reaction, and cyanation of the furan 3ll to produce the nitrile 5, which underwent hydrolysis in 98% yield to give the F-acid.[42] Similarly, the furan 3cc was converted into the nitrile 6, which was hydrolyzed in 98% yield to produce hydromumiamicin,[43] an F-acid derivative in the actinomycete strain Mumia sp. YSP-2–79 with antimicrobial and antioxidant activity. While several syntheses have been reported of F-acids featuring long carboxyalkyl chains, our present total syntheses are the first for F-acids having a three-carbon carboxyalkyl chain.[44] While many efficient methods are available for the syntheses of 2,3-disubstituted furanoterpenes, F-acids, and their derivatives, only this present approach is applicable to the preparation of all three types of natural products.
To verify the reaction mechanism, we isolated the putative Michael adduct (E)-alkoxyacrylate[45] intermediate 7 and subjected it to the optimized Heck conditions, obtaining the furan 3g, albeit in slightly diminished yield when compared with the one-pot procedure (eq. 4). The nascent Michael–Heck adduct 2- furanylideneacetate 3ǵ was also prepared when using the tertiary alcohol 1ǵ (eq. 5). Notably, only (Z)-2-[furan-2(5H)-ylidene]acetate 3ǵ was isolated in 68% yield, supporting the occurrence of stereospecific syn-insertion and syn-elimination during the Heck process (vide infra). While the phosphine-catalyzed Michael addition of primary and secondary alcohols onto alkyl propiolates is well established, examples involving tertiary alcohols are extremely rare and often involve the use of more reactive PMe3.[46] We found, however, that employing PMe3 resulted in the rapid polymerization of methyl propiolate. Tejedor’s insightful report on Lewis base–catalyzed addition of primary, secondary, and tertiary alcohols onto alkyl propiolates suggested that the increased basicity of a tertiary alcohol, as well as the decreased nucleophilicity of the corresponding tertiary alkoxide, made it unable to compete with the dimerization or polymerization of alkyl propiolates in the presence of amines or phosphine catalysts.[17c] To remedy this quandary, we positioned a pKa-lowering CF3-substituent onto the tertiary alcohol.[47] To our delight, we obtained the Michael adduct 8 from 1ǵ in 84% yield. Having verified the feasibility of the DABCO-catalyzed Michael addition of acidic tertiary alcohols onto methyl propiolate, we then subjected 1ǵ to the Heck conditions. Gratifyingly, the small amount of methyl propiolate dimer[48] formed did not interfere with the Heck reaction, and the (Z)-2-[furan-2(5H)-ylidene]acetate 3ǵ was isolated in 68% yield. NOE correlations between the electron-deficient vinyl proton and the ortho phenyl protons confirmed the (Z)-geometry of 3ǵ.
The observations described above underpin the following mechanism for our Michael–Heck reaction (Scheme 3B). Initially, tributylphosphine adds onto the electron-deficient acetylene to produce the zwitterion A, which deprotonates the alcohol 1 to form the corresponding phosphonium alkoxide ion pair B. The alkoxide ion then adds onto the β-phosphonium enoate to produce the zwitterion C, which eliminates tributylphosphine to furnish the Michael adduct 7/8. Subsequent oxidative addition of the Pd(0) complex leads to D, which undergoes syn-carbopalladation to produce the dihydrofuran intermediate E. After rotation about the C–C single bond, the resulting intermediate F undergoes stereospecific syn-β-hydride elimination to generate (Z)-2-[furan-2(5H)-ylidene]acetate G, which spontaneously undergoes aromatization to give the desired furan products when one of the C5 substituents is a hydrogen atom.
Scheme 3.

Mechanistic investigations
In conclusion, we have developed a Michael–Heck protocol for the versatile synthesis of furans of various substitution patterns from (Z)-3-halo-2-propen-1-ols and propiolates. Notably, this method produced, for the first time, furans substituted with four different alkyl groups. The C2-carboxymethyl group derived from the propiolate can then be used conveniently as a handle for further transformations. We have demonstrated the applicability of this new protocol through total syntheses of the P. simplex marine sponge natural products plakorsins A, B, and D and plakorsin D methyl ester; the furanoterpenes rosefuran, sesquirosefuran, and mikanifuran; and the F-acids 3D5 and hydromumiamicin. Employing (Z)-β-halo allylic alcohols, which are readily available, this method offers a general entry to the direct and regioselective syntheses of F-acids and other biologically important polyalkyl furans.
Supplementary Material
Acknowledgments
Financial support for this study was provided by the NIH (R01GM071779). We thank Dr. Yi Chiao Fan for his initial studies into furan synthesis based on the Michael-Heck process.
References
- [1].a) Ochi M, Yamada K, Kawakami H, Tatsukawa A, Kotsuki H, Shibata K, Tetrahedron Lett. 1992, 33, 7531–7534; [Google Scholar]; b) Boto A, Ivarez L, Heterocycles in Natural Products Synthesis, Majumdar KC, Chattopadhyay SK, Wiley-VCH, Weinheim, 2011, pp 97–152. [Google Scholar]; c) Katritzky AR, Advanced Heterocyclic Chemistry, Academic Press, New York, 1982; [Google Scholar]; d) Craig RA, Stoltz BM, Chem. Rev 2017, 117, 7878–7909. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].a) Pozharskii AF, Soldatenkov AT, Katritzky AR, Heterocycles in Life and Society, Wiley, Chichester, 1997; [Google Scholar]; b) Sperry JB, Wright DL, Curr. Opin. Drug Discovery Dev, 2011, 8, 723–740; [PubMed] [Google Scholar]; c) Banerjee R, Kumar H, Banerjee M, Int. J. Rev. Life. Sci, 2012, 2, 7–16. [Google Scholar]
- [3].a) Martin SF, Guinn DE, Tetrahedron Lett. 1984, 25, 5607–5610; [Google Scholar]; b) Lipshutz BH, Chem. Rev 1986, 86, 795–819. [Google Scholar]
- [4].a) Bartelt RJ, Cosse AA, Zilkowski BW, Weisleder D, Grode SH, Wiedenmann RN, Post SL, J. Chem. Ecol 2006, 32, 693–712; [DOI] [PubMed] [Google Scholar]; b) Petroski RJ, Bartelt RJ, Vermillion K, Synth. Commun 2009, 39, 1389–1405. [Google Scholar]
- [5].a) Spiteller G, Lipids 2005, 40, 755–771; [DOI] [PubMed] [Google Scholar]; b) Lemke RAS, Peterson AC, Ziegelhoffer EC, Westphall MS, Tjellstrom H, Coon JJ, Donohue TJ, Proc. Natl. Acad. Sci. USA 2014, 111, 3450–3457; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Xu L, Sinclair AJ, Faiza M, Li D, Han X, Yin H, Wang Y, Prog. Lipid Res 2017, 68, 119–137. [DOI] [PubMed] [Google Scholar]; d) Wakimoto T, Kondo H, Nii H, Kimura K, Egami Y, Oka Y, Yoshida M, Kida E, Ye Y, Akahoshi S, Asakawa T, Matsumura K, Ishida H, Nukaya H, Tsuji K, Kan T, Abe I. Proc. Natl. Acad. Sci. USA 2011, 108, 17533–17537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].a) Weyerstahl P, Schenk A, Marschall H, Liebigs Ann. 1995, 1849–1853; [Google Scholar]; b) Mori N, Kuwahara Y, Kurosa K, J. Chem. Ecol 1998, 24, 1771–1779; [Google Scholar]; c) Mori N, Kuwahara Y, J. Chem. Ecol 2000, 26, 1299–1309. [Google Scholar]
- [7].a) Zhang J, Tang X, Li J, Li P, de Voogd NJ, Ni X, Jin X, Yao X, Li P, Li G, J. Nat. Prod 2013, 76, 600–606; [DOI] [PubMed] [Google Scholar]; b) Chianese G, Yu H-B, Yang F, Sirignano C, Luciano P, Han B-N, Khan S, Lin H-W, Taglialatela-Scafati O, J. Org. Chem 2016, 81, 5135–5143. [DOI] [PubMed] [Google Scholar]
- [8].a) Al-Busafi S, Whitehead RC, Tetrahedron Lett. 2000, 41, 3467–3470; [Google Scholar]; b) Shen YC, Prakash CV, Kuo YH, J. Nat. Prod 2001, 64, 324–327; [DOI] [PubMed] [Google Scholar]; c) Al-Busafi S, Doncaster JR, Drew MGB, Regan AC, Whitehead RC, J. Chem. Soc., Perkin Trans 1 2002, 476–484; [Google Scholar]; d) Etchells LL, Sardarian A, Whitehead RC, Tetrahedron Lett. 2005, 46, 2803–2807; [Google Scholar]; e) Doncaster JR, Etchells LL, Kershaw NM, Nakamura R, Ryan H, Takeuchi R, Sakaguchi K, Sardiarian A, Whitehead RC, Bioorg. Med. Chem. Lett 2006, 16, 2877–2881. [DOI] [PubMed] [Google Scholar]
- [9].a) Kojiima Y, Wakita S, Kato N, Tetrahedron Lett. 1979, 20, 4577–4580; [Google Scholar]; b) Tanis SP, Herrinton PM, J. Org. Chem 1983, 48, 4572–4580 [Google Scholar]
- [10].Selected examples:; a) Kao TT, Syu S, Jhang YW, Lin W. Org. Lett 2010, 12, 3066–3069; [DOI] [PubMed] [Google Scholar]; b) Reddy CR, Reddy MD, J. Org. Chem 2014, 79, 106–116;24325266 [Google Scholar]; c) Han YY, Jiao YY, Ren D, Hu Z, Shen S, Yu S, Asian J Org. Chem 2017, 6, 414–417; [Google Scholar]; d) Yuan Y, Tan H, Kong L, Zheng Z, Xu M, Huang J, Li Y, Org. Biomol. Chem 2019, 17, 2725–2733. [DOI] [PubMed] [Google Scholar]
- [11].Selected examples:; a) Lou J, Wang Q, Wu K, Wu P, Yu Z, Org. Lett 2017, 19, 3287–3290; [DOI] [PubMed] [Google Scholar]; b) Ryu T, Eom D, Shin S, Son JU, Lee PH, Org. Lett 2017, 19, 452–455; [DOI] [PubMed] [Google Scholar]; c) Wang Q, Liu Z, Lou J, Yu Z, Org. Lett 2018, 20, 6007–6011; [DOI] [PubMed] [Google Scholar]; d) Gharpure SJ, Prasath PV, Shelke YG, Org. Lett 2019, 21, 223–227. [DOI] [PubMed] [Google Scholar]
- [12].Selected examples:; a) Fayol A, Zhu J, Org. Lett 2004, 6, 115–118; [DOI] [PubMed] [Google Scholar]; b) Cheng C, Liu S, Zhu G, Org. Lett 2015, 17, 1581–1584; [DOI] [PubMed] [Google Scholar]; c) Kumari ALS, Swamy KCK, J. Org. Chem 2016, 81, 1425–1433;26771256 [Google Scholar]; d) Cai H, Thombal RS, Li X, Lee YR, Adv. Synth. Catal 2019, 361, 4022–4032. [Google Scholar]
- [13].Selected examples:; a) Dudnik AD, Sromek AW, Rubina M, Kim JT, Kel’I AV, Gevorgyan V, J. Am. Chem. Soc 2008, 130, 1440–1452; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Okamoto N, Yanada R, J. Org. Chem 2012, 77, 3944–4951; [DOI] [PubMed] [Google Scholar]; c) Cho CH, Shi F, Jung DI, Neuenswander B, Lushington GH, Larock RC, ACS Comb. Sci 2012, 14, 403–414; [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Ram RN, Gupta DK, Soni VK, J. Org. Chem 2016, 81, 1665–1674; [DOI] [PubMed] [Google Scholar]; e) Kondoh A, Aita K, Ishiwaka S, Terada M, Org. Lett 2020, 22, 2105–2110. [DOI] [PubMed] [Google Scholar]
- [14].To the best of our knowledge, the following reports are the only ones describing the syntheses of tetraalkyl furans:; a) Chai Z, Xie ZF, Liu XY, Zhao G, Wang JD, J. Org. Chem 2008, 73, 2947–2950; [DOI] [PubMed] [Google Scholar]; b) Chobanov NM, Shaibakova MG, Popod’ko NR, Khafizova LO, Dzhemilev UM, Tetrahedron 2017, 73, 5639–5645; [Google Scholar]; c) Khafizova LO, Chobanov NM, Shaibakova MG, Popod’ko NR, Tyumkina TV, Dzhemilev UM, Tetrahedron 2018, 74, 2482–2487; [Google Scholar]; see the Supporting Information for a list of the syntheses of 90 tetrasubstituted furans.
- [15].For examples of aryl-containing furan natural products, furoguaiacidin diethyl ether, shikonofurans A–E, and roseophilin, see:; a) Schreiber FG, Stevenson R, J. Org. Chem 1975, 40, 386–387; [Google Scholar]; b) Yoshizaki F, Hisamichi S, Kondo Y, Sato Y, Nozoe S, Chem. Pharm. Bull 1982, 30, 4407–4411; [Google Scholar]; c) Frederich JH, Harran PG, J. Am. Chem. Soc 2013, 135, 3788–3791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Synthesis of (Z)-3-iodo-2-propen-1-ols:; a) Duboudin JG, Jousseaume B, Bonakdar A, Saux A, J. Organomet. Chem 1979, 168, 227–232; [Google Scholar]; b) Cowell A, Stille JK, J. Am. Chem. Soc 1980, 102, 4193–4198. [Google Scholar]
- [17].a) Inanaga J, Baba Y, Hanamoto T, Chem. Lett 1993, 2, 241–244; [Google Scholar]; b) Ramazani A, Pakravan BP, Bandpey M, Noshiranzadeh N, Souldozi A, Phosphorus, Sulfur Silicon Relat. Elem 2007, 182, 1633–1640; [Google Scholar]; c) Tejedor D, Alvarez-Mendez SJ, Lopez-Soria JM, Martin VS, Garcia-Tellado F, Eur. J. Org. Chem 2014, 2014, 198–205. [Google Scholar]
- [18].Although the Michael addition step precludes the preparation of 3-substituted and 3,4-disubstituted furans, the stability of 3-furfuryl halides (in stark contrast to their 2-substituted homologues) enables ready access to 3-furfuryl derivatives that can be used in the total syntheses of various 3-substituted furan natural products. For the difference in stability between 3- and 2-furfuryl derivatives, see:; Sherman E, Amstutz ED, J. Am. Chem. Soc 1950, 72, 2195–2199. [Google Scholar]
- [19].Examples of total syntheses of 3-substituted furan natural products using 3-furfuryl derivatives:; a) P Tanis S, Tetrahedron Lett. 1982, 23, 3115–3118; [Google Scholar]; b) Noda Y, Ugajin S, Yamanaka A, Mamiya N, Heterocycles 2011, 83, 2265–2269; [Google Scholar]; c) Tan DX, Xu ZJ, Chen HJ, Wu Y, You J, Eur. J. Org. Chem 2016, 946–957; [Google Scholar]; d) Serra S, Mar. Drugs 2019, 17, 245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].The ready availability of various 3,4-disubstituted furan precursors also facilitates total syntheses of 3,4-disubstituted furan natural products. For examples, see:; a) Tanis SP, Head DB, Tetrahedron Lett. 1982, 23, 5509–5512; [Google Scholar]; b) Song ZZ, Ho MS, C Wong HN, J. Org. Chem 1994, 59, 3917–3926. [Google Scholar]
- [21].For the role of water in the generation of active Pd(0) complexes from Pd(II) in the Heck reaction, see:; a) Ozawa F, Kubo A, Hayashi T, Chem. Lett 1992, 21, 2177–2180; [Google Scholar]; b) Amatore C, Jutand A, Thuilliez A, Organometallics 2001, 20, 3241–3249. [Google Scholar]
- [22].a) Jeffery TJ, J. Chem. Soc., Chem. Commun 1984, 1287–1289; [Google Scholar]; b) Jeffery T, Tetrahedron Lett. 1985, 26, 2667–2670. [Google Scholar]
- [23].Bures E, Spinazze PG, Beese G, Hunt IR, Rogers C, Keay BA, J. Org. Chem 1997, 62, 8741–8749. [Google Scholar]
- [24].a) Netherton MR, Fu GC, Org. Lett 2001, 3, 4295–4298; [DOI] [PubMed] [Google Scholar]; b) Littke AF, Fu GC, J. Am. Chem. Soc 2001, 123, 6989–7000. [DOI] [PubMed] [Google Scholar]
- [25].Examples of 2-trifluoromethylfurans:; Wang J, Chen S, Wu W, Wen S, Weng Z, J. Org. Chem 2019, 84, 15685–15696. [DOI] [PubMed] [Google Scholar]
- [26].a) Kirsch P, Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications, Wiley-VCH, Weinheim, 2013, pp. 299–350; [Google Scholar]; b) Gomes MN, Muratov EN, Pereira M, Peixoto JC, Rosseto LP, Cravo PVL, Andrade CH, Neves BJ, Molecules 2017, 22, 1210–1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Hayes SJ, Knight DW, Smith AWT, O’Halloran MJ, Tetrahedron Lett. 2010, 51, 717–719. [Google Scholar]
- [28].Kalaitzakis D, Triantafyllakis M, Alexopoulou I, Sofiadis M, Vassilikogiannakis G. Angew. Chem. Int. Ed 2014, 53, 13201–13205. [DOI] [PubMed] [Google Scholar]
- [29].a) Al-Busafi S, Whitehead RC, Tetrahedron Lett. 2000, 41, 3467–3470; [Google Scholar]; b) Etchells LL, Sardarian A, Whitehead RC, Tetrahedron Lett. 2005, 46, 2803–2807; [Google Scholar]; c) Doncaster JR, Etchells LL, Kershaw NM, Nakamura R, Ryan H, Takeuchi R, Skaguchi K, Sardarian A, Whitehead RC, Bioorg. Med. Chem. Lett 2006, 16, 2877–2881. [DOI] [PubMed] [Google Scholar]
- [30].Al-Busafi S, Doncaster JR, Drew MGB, Regan AC, Whitehead RC, J. Chem. Soc., Perkin Trans 1 2002, 476–484. [Google Scholar]
- [31]. Although plakorsin D methyl ester has not been prepared de novo, it, along with another furanylidene P. simplex natural product, has been demonstrated to arise from the FeCl3-mediated rearrangement of the cyclic endoperoxide analogue of plakodiepoxide derived from P. simplex sponges; see ref. [7b].; Lee RJ, Lindley MR, G. J. Pritchard, Kimber MC, Chem. Commun 2017, 53, 6327–6330. [DOI] [PubMed] [Google Scholar]
- [32].Ishibashi H, Tabata T, Kobayashi T, Takamuro I, Ikeda M, Chem. Pharm. Bull 1991, 39, 2878–2882. [Google Scholar]
- [33].For the relative stabilities of 2-furfuryl halides, see:; a) Zanetti JE, J. Am. Chem. Soc 1927, 49, 1061–1065; [Google Scholar]; b) Zanetti JE, Bashour JT, J. Am. Chem. Soc 1939, 61, 2249–2251. [Google Scholar]
- [34].Performing the reaction at the melting point of PPh3 allows it to be used as a solvent:; Cobb JE, Cribbs CM, Henke BR, Uehling DE. Triphenylphosphine. In e-EROS Encyclopedia of Reagents for Organic Synthesis, Wiley, 2005; DOI: 10.1002/047084289X.rt366. [DOI] [Google Scholar]
- [35].Boden RM, Synthesis 1975, 784. [Google Scholar]
- [36].Tanaka H, Takaya Y, Toyoda J, Yasuda T, Sato M, Murata J, Murata H, Kaburagi K, Iida O, Sugimura K, Sakai E, Phytochem. Lett 2015, 11, 32–36. [Google Scholar]
- [37].a) Kato T, Tanemura M, Kanno S, Suzuki T, Kitahara Y, Bioorg. Chem 1971, 1, 84–90; [Google Scholar]; b) Kramp W, Bohlmann F, Liebigs. Ann. Chem 1986, 226–233. [Google Scholar]
- [38].A similar E2-elimination has been observed in the basic decomposition of β-phenethylphosphonium bromides:; Alunni S, Giulietti G, Z. Naturforsch. B 2014, 38, 115–116. [Google Scholar]
- [39].An example of an E-selective Wittig reaction:; Oh JS, Kim BH, Kim YG, Tetrahedron Lett. 2004, 45, 3925–3928. [Google Scholar]
- [40].Robiette R, Richardson J, Aggarwal VK, Harvey JN, J. Am. Chem. Soc 2006, 128, 2394–2409. [DOI] [PubMed] [Google Scholar]
- [41]. Examples include alkylations of (3-furylmethyl)indate[41] and 2,2´-di-3-methylfurylmercury with prenyl,[42a] geranyl,[42b,c] and farnesyl[42d] bromides; Au(I)-,[43a] Ir(I)-,[43b] and Pd(II)[43c,d]-catalyzed cycloisomerizations of (Z)-2-en-4-yn-1-ols; reductions of prenyl-[44a] and geranyl[44b–d]-substituted furanones; and cyclizations of α-allenic alcohols.[45] In the case of mikanifuran, alkylation of geranyl p-tolyl sulfone with the allylic chloride derivative[46] prepared from rosefuran has also been reported. See the Supporting Information for a full list of previous syntheses.
- [42].a) Jie LK, Marcel SF, Methods Enzymol. 1981, 72, 443–471; [DOI] [PubMed] [Google Scholar]; b) Groweiss Y, Kashman A, Cell. Mol. Life Sci 1978, 34, 299; [Google Scholar]; c) Imbs AB, Russ J Mar. Biol 2013, 39, 153–168. [Google Scholar]
- [43].Kimura T, Tajima A, Inahashi Y, Iwatsuki M, Kasai H, Mokudai T, Niwano Y, Shiomi K, Takahashi Y, Omura S, Nakashima T, J. Gen. Appl. Microbiol 2018, 64, 62–67. [DOI] [PubMed] [Google Scholar]
- [44]. In addition to the strategies used for the preparation of plakorsin natural products and 2,3-disubstituted furanoterpenes, rearrangements of cyclic endoperoxides[31b] and catalytic isomerization of cyclic epoxyalkynols[49] have also been reported for the synthesis of 11M5 and its methyl ester. Other syntheses include lithiation/alkylation of 3-iodofurans;[50] Sonogashira[51] and Negishi[51] couplings of methyl 4,5-dibromofurano-2-carboxylate; electrophilic aromatic substitution[52] of methyl 3-methyl-2-furoate; and reduction/iodination/reduction[53] of 3-ethoxycarbonylfurans. See the Supporting Information for a list of previous syntheses.
- [45].The coupling constants (J) for the vinyl protons of methyl (Z)-β-alkoxyacrylates range from 6.7 to 7.2 Hz, in contrast to values of approximately 12 Hz for corresponding E isomers. For examples, see:; a) Singh SP, O’Donnell JS, Schwan AL. Org. Biomol. Chem 2010, 8, 1712–1717; [DOI] [PubMed] [Google Scholar]; b) Sarrafi Y, Sadatshahabi M, Alimohammadi K, Tajbakhsh M. Green. Chem 2011, 13, 2851–2858; [Google Scholar]; c) Bergbreiter DE, Yang Y-C, Hobbs CE, J. Org. Chem 2011, 76, 6912–6917. [DOI] [PubMed] [Google Scholar]
- [46].Examples of PMe3-catalyzed addition of tertiary alcohols onto methyl propiolate:; a) Sato K, Sasaki M. Org. Lett 2005, 7, 2441–2444; [DOI] [PubMed] [Google Scholar]; b) Sato K, Sasaki M. Tetrahedron 2007, 63, 5977–6003; [Google Scholar]; c) Davy JA, Mason JW, Moreau B, Wulff JE. J. Org. Chem 2012, 77, 6332–6339; [DOI] [PubMed] [Google Scholar]; d) Kunitake M, Oshima T, Konoki K, Ebine M, Torikai K, Murata M, Oishi T, J. Org. Chem 2014, 79, 4948–4962. [DOI] [PubMed] [Google Scholar]
- [47]. While an alkynyl group would lower the pKa of a tertiary alcohol by approximately 2 units, replacing one of the methyl groups in tert-butanol by a CF3 group would lower the pKa from 17 to 12.6 (a change of 4.4 units). See ref. 17c.
- [48].DABCO is known to quantitatively dimerize methyl propiolate to (E)-hex-2-en-4-ynedioic acid dimethyl ester:; a) Matsuya Y, Hayashi K, Nemoto H, J. Am. Chem. Soc 2003, 125, 646–647; [DOI] [PubMed] [Google Scholar]; b) Zhou L-H, Yu X-Q, Pu L, Tetrahedron Lett. 2010, 51, 425–427; [Google Scholar]; c) Puenner F, Hilt G, Chem. Commun 2012, 48, 3617–3619; [DOI] [PubMed] [Google Scholar]; d) Choi J-H, Park C-M, Adv. Synth. Catal 2018, 360, 3553–3562. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



